Arlington Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.2K | Hold |
1,118
| – | – | 0.02% | 300 |
|
|
2025
Q1 | $77.6K | Hold |
1,118
| – | – | 0.02% | 305 |
|
|
2024
Q4 | $96.2K | Hold |
1,118
| – | – | 0.02% | 272 |
|
|
2024
Q3 | $133K | Hold |
1,118
| – | – | 0.03% | 218 |
|
|
2024
Q2 | $160K | Hold |
1,118
| – | – | 0.04% | 181 |
|
|
2024
Q1 | $144K | Hold |
1,118
| – | – | 0.04% | 175 |
|
|
2023
Q4 | $116K | Sell |
1,118
-30,234
| -96% | -$3.13M | 0.03% | 204 |
|
|
2023
Q3 | $2.85M | Buy |
+31,352
| New | +$2.85M | 1.17% | 26 |
|